• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NMMHC-A基因的突变会导致常染色体显性遗传性大血小板减少症并伴有白细胞包涵体(May-Hegglin异常/塞巴斯蒂安综合征)。

Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).

作者信息

Kunishima S, Kojima T, Matsushita T, Tanaka T, Tsurusawa M, Furukawa Y, Nakamura Y, Okamura T, Amemiya N, Nakayama T, Kamiya T, Saito H

机构信息

First Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya, Japan.

出版信息

Blood. 2001 Feb 15;97(4):1147-9. doi: 10.1182/blood.v97.4.1147.

DOI:10.1182/blood.v97.4.1147
PMID:11159552
Abstract

Macrothrombocytopenia with leukocyte inclusions is a rare autosomal dominant platelet disorder characterized by a triad of giant platelets, thrombocytopenia, and characteristic Döhle body-like leukocyte inclusions. A previous study mapped a locus for the disease on chromosome 22q12.3-q13.2 by genome-wide linkage analysis. In addition, the complete DNA sequence of human chromosome 22 allowed a positional candidate approach, and results here indicate that the gene encoding nonmuscle myosin heavy chain-A, NMMHC-A, is mutated in this disorder. Mutations were found in 6 of 7 Japanese families studied: 3 missense mutations, a nonsense mutation, and a one-base deletion resulting in a premature termination. Immunofluorescence studies revealed that NMMHC-A distribution in neutrophils appeared to mimic the inclusion bodies. These results provide evidence for the involvement of abnormal NMMHC-A in the formation of leukocyte inclusions and also in platelet morphogenesis.

摘要

伴有白细胞包涵体的大血小板减少症是一种罕见的常染色体显性血小板疾病,其特征为三联征:巨大血小板、血小板减少症以及特征性的似杜勒小体的白细胞包涵体。先前的一项研究通过全基因组连锁分析将该疾病的一个基因座定位在22号染色体的q12.3 - q13.2区域。此外,人类22号染色体的完整DNA序列使得采用位置候选基因法成为可能,此处的研究结果表明,编码非肌肉肌球蛋白重链A(NMMHC - A)的基因在该疾病中发生了突变。在所研究的7个日本家族中的6个发现了突变:3个错义突变、1个无义突变以及1个导致提前终止的单碱基缺失。免疫荧光研究显示,NMMHC - A在中性粒细胞中的分布似乎与包涵体相似。这些结果为异常的NMMHC - A参与白细胞包涵体的形成以及血小板形态发生提供了证据。

相似文献

1
Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).NMMHC-A基因的突变会导致常染色体显性遗传性大血小板减少症并伴有白细胞包涵体(May-Hegglin异常/塞巴斯蒂安综合征)。
Blood. 2001 Feb 15;97(4):1147-9. doi: 10.1182/blood.v97.4.1147.
2
Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.常染色体显性遗传性大血小板减少伴白细胞包涵体中六个新的MYH9突变的鉴定及基因型-表型关系
J Hum Genet. 2001;46(12):722-9. doi: 10.1007/s100380170007.
3
Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.May-Hegglin异常中编码非肌肉肌球蛋白重链A的MYH9突变。
Nat Genet. 2000 Sep;26(1):106-8. doi: 10.1038/79069.
4
Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.天冬酰胺酸1424位点突变的肌球蛋白重链9(MYH9)会产生一种不稳定蛋白质,该蛋白质与May-Hegglin异常/Fechtner综合征的表型有关。
Blood. 2003 Jul 15;102(2):529-34. doi: 10.1182/blood-2002-09-2783. Epub 2003 Mar 20.
5
[May-Hegglin anomaly--from genome research to clinical laboratory].[迈-赫二氏异常——从基因组研究到临床实验室]
Rinsho Byori. 2003 Sep;51(9):898-904.
6
Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.MYH9基因的突变会导致May-Hegglin异常以及Fechtner和Sebastian综合征。May-Heggllin/Fechtner综合征研究联盟。
Nat Genet. 2000 Sep;26(1):103-5. doi: 10.1038/79063.
7
A notable case report of May-Hegglin anomaly with immune complex-related nephropathy: a genetic and histological analysis.一例伴有免疫复合物相关肾病的May-Hegglin异常的显著病例报告:基因与组织学分析
Clin Nephrol. 2011 Mar;75(3):255-62. doi: 10.5414/cnp75255.
8
[Usefulness of immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A for diagnosing in two sisters with May-Hegglin anomaly].[中性粒细胞非肌肉肌球蛋白重链A免疫荧光分析在诊断两名患有May-Hegglin异常的姐妹中的应用]
Rinsho Ketsueki. 2008 Dec;49(12):1614-8.
9
Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.非肌肉肌球蛋白重链IIA突变定义了一系列常染色体显性大血小板减少症:May-Hegglin异常以及Fechtner、Sebastian、Epstein和Alport样综合征。
Am J Hum Genet. 2001 Nov;69(5):1033-45. doi: 10.1086/324267. Epub 2001 Oct 4.
10
[Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].[伴有白细胞包涵体的常染色体显性大血小板减少症与MYH9相关疾病]
Rinsho Byori. 2009 Apr;57(4):365-70.

引用本文的文献

1
myh9b is a critical non-muscle myosin II encoding gene that interacts with myh9a and myh10 during zebrafish development in both compensatory and redundant pathways.myh9b是一个关键的非肌肉肌球蛋白II编码基因,在斑马鱼发育过程中,它在补偿和冗余途径中与myh9a和myh10相互作用。
G3 (Bethesda). 2025 Jan 8;15(1). doi: 10.1093/g3journal/jkae260.
2
MYH9-related disease with a normal platelet count.血小板计数正常的MYH9相关疾病。
CEN Case Rep. 2025 Apr;14(2):141-144. doi: 10.1007/s13730-024-00922-x. Epub 2024 Aug 3.
3
Platelet formation and activation are influenced by neuronal guidance proteins.
血小板的形成和激活受神经元导向蛋白的影响。
Front Immunol. 2023 Jun 15;14:1206906. doi: 10.3389/fimmu.2023.1206906. eCollection 2023.
4
Unique and redundant functions of cytoplasmic actins and nonmuscle myosin II isoforms at epithelial junctions.细胞质肌动蛋白和非肌肉肌球蛋白 II 同工型在细胞连接中的独特和冗余功能。
Ann N Y Acad Sci. 2022 Sep;1515(1):61-74. doi: 10.1111/nyas.14808. Epub 2022 Jun 7.
5
R702C is associated with erythroid abnormality with splenomegaly in mice.R702C与小鼠红细胞异常伴脾肿大有关。
Nagoya J Med Sci. 2021 Feb;83(1):75-86. doi: 10.18999/nagjms.83.1.75.
6
Two Cases of the Disorder Fechtner Syndrome Diagnosed from Observation of Peripheral Blood Cells before End-Stage Renal Failure.两例终末期肾衰竭前通过外周血细胞观察诊断的费希特纳综合征病例
Case Rep Nephrol. 2019 Nov 26;2019:5149762. doi: 10.1155/2019/5149762. eCollection 2019.
7
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants.下一代测序在 MYH9-RD 诊断中的应用:致病性变异的预测。
Hum Mutat. 2020 Jan;41(1):277-290. doi: 10.1002/humu.23927. Epub 2019 Oct 15.
8
Novel mutations associated with autosomal-dominant congenital cataract identified in Chinese families.在中国家庭中鉴定出与常染色体显性先天性白内障相关的新型突变。
Exp Ther Med. 2019 Oct;18(4):2701-2710. doi: 10.3892/etm.2019.7865. Epub 2019 Aug 8.
9
MYH9-related disorders display heterogeneous kidney involvement and outcome.与MYH9相关的疾病表现出肾脏受累情况和预后的异质性。
Clin Kidney J. 2018 Dec 17;12(4):494-502. doi: 10.1093/ckj/sfy117. eCollection 2019 Aug.
10
Renin-angiotensin System Blockade Therapy for Early Renal Involvement in MYH9-related Disease with an E1841K Mutation.肾素-血管紧张素系统阻断疗法用于治疗E1841K突变的MYH9相关疾病早期肾脏受累情况
Intern Med. 2019 Oct 15;58(20):2983-2988. doi: 10.2169/internalmedicine.2997-19. Epub 2019 Jun 27.